Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FWFCH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,893
Award facts
- Contract value 100% obligated
- $1,892.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 20, 2025, for NUCALA 100 mg/mL auto-injectors. The contract is valued at $1,892.90 and carries a firm fixed-price structure with an ultimate completion date of August 21, 2025. This delivery order was issued without a set-aside designation, demonstrating the company's competitive positioning in federal pharmaceutical procurement. The place of performance is located at the vendor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs across Department of Defense healthcare facilities worldwide. NUCALA (reslizumab), a specialty injectable medication, represents the type of biologics and specialty pharmaceuticals the company routinely supplies to federal healthcare systems as part of its established role as a critical supplier in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FWFCH?
SPE2DB25FWFCH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FWFCH worth?
The government has obligated $1,893 on SPE2DB25FWFCH.
Is contract SPE2DB25FWFCH an order under another contract?
Yes. SPE2DB25FWFCH is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFCH competed?
The extent of competition for SPE2DB25FWFCH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award